1. FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE. (25th March 2021) Authors: Pham, Khoa; Poore, Brad; Hanaford, Allison; Maxwell, Micah J; Sweeney, Heather; Parthasarathy, Akhila; Alt, Jesse; Rais, Rana; Slusher, Barbara S; Eberhart, Charles G; Raabe, Eric H Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 1 Page Start: i19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Issue 10 (20th May 2019) Authors: Soomro, Irfana; Sun, Ying; Li, Zhai; Diggs, Lonnette; Hatzivassiliou, Georgia; Thomas, Ajit G; Rais, Rana; Parker, Seth J; Slusher, Barbara S; Kimmelman, Alec C; Somlo, Stefan; Skolnik, Edward Y Journal: Nephrology dialysis transplantation Issue: Volume 35:Issue 10(2020) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Issue 8 (5th February 2018) Authors: Soomro, Irfana; Sun, Ying; Li, Zhai; Diggs, Lonnette; Hatzivassiliou, Georgia; Thomas, Ajit G; Rais, Rana; Slusher, Barbara S; Somlo, Stefan; Skolnik, Edward Y Journal: Nephrology dialysis transplantation Issue: Volume 33:Issue 8(2018) Page Start: 1343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis. Issue 4 (22nd March 2021) Authors: Pham, Khoa; Maxwell, Micah J; Sweeney, Heather; Alt, Jesse; Rais, Rana; Eberhart, Charles G; Slusher, Barbara S; Raabe, Eric H Journal: Journal of neuropathology and experimental neurology Issue: Volume 80:Issue 4(2021) Page Start: 336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect. (September 2016) Authors: Rojas, Camilo; Alt, Jesse; Ator, Nancy A; Wilmoth, Heather; Rais, Rana; Hin, Niyada; DeVivo, Michael; Popiolek, Michael; Tsukamoto, Takashi; Slusher, Barbara S Journal: Journal of psychopharmacology Issue: Volume 30:Number 9(2016:Sep.) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage. (5th July 2021) Authors: Pham, Khoa; Poore, Brad; Hanaford, Allison; Maxwell, Micah J; Sweeney, Heather; Parthasarathy, Akhila; Alt, Jesse; Rais, Rana; Slusher, Barbara S; Eberhart, Charles G; Raabe, Eric H Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Spontaneous Loss-of-Function Dock2 Mutation Alters Murine Colitis Sensitivity and Is a Confounding Variable in Inflammatory Bowel Disease Research. Issue 3 (26th September 2019) Authors: Peters, Diane E; Norris, Lauren D; Slusher, Barbara S Journal: Crohn's & colitis 360 Issue: Volume 1:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling. Issue 1 (29th October 2020) Authors: Yamashita, Alex Shimura; da Costa Rosa, Marina; Stumpo, Vittorio; Rais, Rana; Slusher, Barbara S; Riggins, Gregory J Journal: Neuro-oncology advances Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The neutral sphingomyelinase 2 inhibitor PDDC reduces tau burden in Alzheimer's disease mice. (31st December 2021) Authors: Tallon, Carolyn; Bell, Benjamin J; Malvankar, Medhinee; Hollinger, Kristen R; Thomas, Ajit G; Yoo, Seung Wan; Chaudhuri, Amrita Datta; Wu, Ying; Rais, Rana; Haughey, Norman J; Slusher, Barbara S Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗